As the coronavirus pandemic spreads across the globe, putting unprecedented pressure on social, health, and economic systems, scientists are working around the clock to develop vaccine candidates and diagnostic tests in record time. Intellectual property in the form of patented biosequences and chemical structures may play a role in helping researchers better understand the disease and bring potential treatments to fruition. These extraordinary, collaborative, and fast-tracked scenarios are playing out in labs all over the world and have put the biotechnological innovation at the forefront and raised some important questions for the biopharma patent community with regard to the state of innovation for the public good, today and in the future.

You are invited to hear Brian Larner and Dr. Cornelius Enuezie to discuss the trends shaping the biosequence technology landscape.

This webinar is held in conjunction with Singapore IP Week 2020. IP Week is going digital for the first time this year and it will be held from 25 to 27 August 2020. To learn more, visit https://www.ipweek2020.sg/